Page 1 | Search Results | Blood | American Society of Hematology

1-14 of 14

Sort by

Sort Order Select

Journal Articles

The HLA ligandome landscape of chronic myeloid leukemia delineates novel T-cell epitopes for immunotherapy

Blood (2019) 133 (6): 550–565.

https://doi.org/10.1182/blood-2018-07-866830

Published: 2019

Includes: Supplemental data

Journal Articles

HLA Ligandome Analysis of Primary Chronic Lymphocytic Leukemia (CLL) Cells Under In Vitro Lenalidomide Treatment Confirms Lenalidomide as a Suitable Combination Partner for T-Cell Based Immunotherapy

Annika Nelde, Daniel J. Kowalewski, Linus Backert, Heiko Schuster, Lothar Kanz, MD, Helmut R. Salih, MD, Hans-Georg Rammensee, PhD, Stefan Stevanovic, PhD, Juliane S. Stickel, MD

Blood (2016) 128 (22): 3234.

https://doi.org/10.1182/blood.V128.22.3234.3234

Published: 2016

Journal Articles

Identification of Naturally Presented HLA Ligands of Enriched Leukemic Progenitor Cells for Peptide-Based Immunotherapy in Acute Myeloid Leukemia (AML)

Annika Nelde, Heiko Schuster, Daniel J. Kowalewski, Lothar Kanz, MD, Helmut R. Salih, MD, Hans-Georg Rammensee, PhD, Stefan Stevanovic, PhD, Juliane S. Stickel, MD

Blood (2016) 128 (22): 4046.

https://doi.org/10.1182/blood.V128.22.4046.4046

Published: 2016

Journal Articles

Mapping the HLA Ligandome Landscape of Chronic Myeloid Leukemia Identifies Novel CD8 + and CD4 + T Cell-Epitopes for Immunotherapeutic Approaches

Tatjana Bilich, Annika Nelde, Daniel J. Kowalewski, Janet Peper, Mirle Schemionek, PhD, Lothar Kanz, MD, Helmut R. Salih, MD, Tim H. Brümmendorf, MD, Vladan Vucinic, MD, Dietger Niederwieser, MD, Hans-Georg Rammensee, PhD, Stefan Stevanovic, PhD, Juliane S. Stickel, MD

Blood (2016) 128 (22): 4232.

https://doi.org/10.1182/blood.V128.22.4232.4232

Published: 2016

Journal Articles

HLA Ligandome Analysis of Different Hematological Malignancies Identifies a Small Panel of "Pan-Leukemia"-Associated Antigens

Linus Backert, Daniel J. Kowalewski, Simon D. Walz, Heiko Schuster, Claudia Berlin, Mirle Schemionek, PhD, Tim H. Brümmendorf, MD, Vladan Vucinic, MD, Dietger Niederwieser, MD, Lothar Kanz, MD, Helmut R. Salih, MD, Katja Weisel, MD, Hans-Georg Rammensee, PhD, Stefan Stevanovic, PhD, Juliane S. Stickel, MD

Blood (2016) 128 (22): 2169.

https://doi.org/10.1182/blood.V128.22.2169.2169

Published: 2016

Journal Articles

Unique Alterations in the Immunopeptidome of Colorectal Cancer Reflect Specific Transformations in Cancer-Associated Signaling Pathways and Reveal Tumor-Specific HLA-Ligand Modulations

Sebastian P. Haen, MD, Daniel J. Kowalewski, Joerg Bernhardt, Linus Backert, Daniel Backes, Florian Dengler, Stefan Beckert, Ingmar Koenigsrainer, Hans-Georg Kopp, MD, Oliver Kohlbacher, Alfred Koenigsrainer, MD, Lothar Kanz, MD, Hans-Georg Rammensee, PhD, Stefan Stevanovic, PhD, Markus W. Loeffler, MD

Blood (2016) 128 (22): 862.

https://doi.org/10.1182/blood.V128.22.862.862

Published: 2016

Journal Articles

HLA Ligandome Profiling Identifies a Novel Category of Pathophysiologically Relevant CLL Associated Antigens

Daniel J. Kowalewski, Heiko Schuster, Claudia Berlin, Stefan Kahn, Linus Backert, Lothar Kanz, MD, Helmut R. Salih, MD, Hans-Georg Rammensee, PhD, Stefan Stevanovic, PhD, Juliane S. Stickel, MD

Blood (2014) 124 (21): 715.

https://doi.org/10.1182/blood.V124.21.715.715

Published: 2014

Journal Articles

HLA Ligandome Analysis in Primary Polycythemia Vera (PV) Samples Shows No Tumor-Association of Naturally Presented JAK2 Ligands but Reveals a Vast Array of Novel PV-Associated HLA Ligands

Juliane S. Stickel, MD, Daniel J. Kowalewski, Steffen Koschmieder, MD, Lothar Kanz, MD, Helmut R. Salih, MD, Tim H. Brümmendorf, MD, Hans-Georg Rammensee, PhD, Stefan Stevanovic, PhD

Blood (2014) 124 (21): 4581.

https://doi.org/10.1182/blood.V124.21.4581.4581

Published: 2014

Journal Articles

Mapping the HLA Ligandome Landscape of Chronic Myeloid Leukemia (CML)—Towards Peptide Based Immunotherapy

Daniel J. Kowalewski, Mirle Schemionek, Lothar Kanz, MD, Helmut R. Salih, MD, Tim H. Brümmendorf, MD, Vladan Vucinic, MD, Dietger Niederwieser, MD, Hans-Georg Rammensee, PhD, Stefan Stevanovic, PhD, Juliane S. Stickel, MD

Blood (2014) 124 (21): 4518.

https://doi.org/10.1182/blood.V124.21.4518.4518

Published: 2014

Journal Articles

HLA Ligandome Analysis in Multiple Myeloma Reveals Novel Naturally Presented Myeloma-Associated Antigens Showing Stable Expression Under Proteasome Inhibitor Therapy

Simon D. Walz, Daniel J. Kowalewski, Heiko Schuster, Katja Weisel, MD, Helmut R. Salih, MD, Lothar Kanz, MD, Hans-Georg Rammensee, PhD, Stefan Stevanovic, PhD, Juliane S. Stickel, MD

Blood (2014) 124 (21): 3438.

https://doi.org/10.1182/blood.V124.21.3438.3438

Published: 2014

Journal Articles

Mapping The HLA Ligandome Of Chronic Lymphocytic Leukemia – Towards Peptide Based Immunotherapy

Daniel J. Kowalewski, Heiko Schuster, Claudia Berlin, Lothar Kanz, MD, Helmut R. Salih, MD, Hans-Georg Rammensee, Stefan Stevanovic, Juliane S. Stickel

Blood (2013) 122 (21): 4123.

https://doi.org/10.1182/blood.V122.21.4123.4123

Published: 2013

Journal Articles

Characterization Of The HLA Class II Ligandome In Acute Myeloid Leukemia (AML) Reveals Novel Candidates For Peptide-Based Immunotherapy

Juliane S. Stickel, Claudia Berlin, Daniel J. Kowalewski, Lothar Kanz, MD, Helmut R. Salih, MD, Hans-Georg Rammensee, Stefan Stevanovic

Blood (2013) 122 (21): 5012.

https://doi.org/10.1182/blood.V122.21.5012.5012

Published: 2013

Journal Articles

HLA Class I Ligandome Analysis In Acute Myeloid Leukemia – Novel T-Cell Epitopes For Peptide-Based Immunotherapy

Stickel S. Juliane, Claudia Berlin, Daniel J. Kowalewski, Heiko Schuster, Lothar Kanz, MD, Helmut R. Salih, MD, Hans-Georg Rammensee, Stefan Stevanovic

Blood (2013) 122 (21): 5431.

https://doi.org/10.1182/blood.V122.21.5431.5431

Published: 2013

Journal Articles

HLA Ligandome Analysis Of Chronic Myeloid Leukemia (CML), Revealed Novel Tumor Associated Antigens For Peptide Based Immunotherapy

Juliane S. Stickel, Daniel J. Kowalewski, Mirle Schemionek, Lothar Kanz, MD, Tim H. Brümmendorf, MD, Helmut R. Salih, MD, Hans-Georg Rammensee, Stefan Stevanovic

Blood (2013) 122 (21): 3975.

https://doi.org/10.1182/blood.V122.21.3975.3975

Published: 2013

NARROW

The HLA ligandome landscape of chronic myeloid leukemia delineates novel T-cell epitopes for immunotherapy

HLA Ligandome Analysis of Primary Chronic Lymphocytic Leukemia (CLL) Cells Under In Vitro Lenalidomide Treatment Confirms Lenalidomide as a Suitable Combination Partner for T-Cell Based Immunotherapy

Identification of Naturally Presented HLA Ligands of Enriched Leukemic Progenitor Cells for Peptide-Based Immunotherapy in Acute Myeloid Leukemia (AML)

Mapping the HLA Ligandome Landscape of Chronic Myeloid Leukemia Identifies Novel CD8 + and CD4 + T Cell-Epitopes for Immunotherapeutic Approaches

HLA Ligandome Analysis of Different Hematological Malignancies Identifies a Small Panel of "Pan-Leukemia"-Associated Antigens

Unique Alterations in the Immunopeptidome of Colorectal Cancer Reflect Specific Transformations in Cancer-Associated Signaling Pathways and Reveal Tumor-Specific HLA-Ligand Modulations

HLA Ligandome Profiling Identifies a Novel Category of Pathophysiologically Relevant CLL Associated Antigens

HLA Ligandome Analysis in Primary Polycythemia Vera (PV) Samples Shows No Tumor-Association of Naturally Presented JAK2 Ligands but Reveals a Vast Array of Novel PV-Associated HLA Ligands

Mapping the HLA Ligandome Landscape of Chronic Myeloid Leukemia (CML)—Towards Peptide Based Immunotherapy

HLA Ligandome Analysis in Multiple Myeloma Reveals Novel Naturally Presented Myeloma-Associated Antigens Showing Stable Expression Under Proteasome Inhibitor Therapy

Mapping The HLA Ligandome Of Chronic Lymphocytic Leukemia – Towards Peptide Based Immunotherapy

Characterization Of The HLA Class II Ligandome In Acute Myeloid Leukemia (AML) Reveals Novel Candidates For Peptide-Based Immunotherapy

HLA Class I Ligandome Analysis In Acute Myeloid Leukemia – Novel T-Cell Epitopes For Peptide-Based Immunotherapy

HLA Ligandome Analysis Of Chronic Myeloid Leukemia (CML), Revealed Novel Tumor Associated Antigens For Peptide Based Immunotherapy

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only